News for the Multiple Sclerosis Community

Antibiotic Able To Reduce Neuronal Cell Death In Brain

Researchers recently reported on the mechanism of action of ceftriaxone, a third-generation antibiotic with neuroprotective properties, in glutamate transport. The findings, published in the May 9 issue of the Journal of Biological Chemistry, suggest that this antibiotic or a similar drug may serve as a potential therapy against neurodegenerative disease caused by glutamate toxicity.

Perhaps this gives some credence to the idea that minocycline could be beneficial in MS.